Table 1.
Causes of Hypertriglyceridemia
| Cause |
|---|
| Genetic (primary) (12, 37, 40) |
| Familial hyperchylomicronemia |
| Autosomal recessive mutations in LPL, APOC2, APOA5, LMF1, GPIHBP1, or GPD1 |
| Increased TGs/chylomicrons |
| Familial combined hyperlipidemia |
| Due to rare variants in genes associated with hypertriglyceridemia |
| Familial hypertriglyceridemia |
| Polygenic |
| Elevated TCs, TGs, apoB |
| Dysbetalipoproteinemia (familial type III) |
| Autosomal recessive mutation in APOE |
| Defective apoE (apo EII/EII phenotype) |
| Increased TC/TG, VLDL remnants, and chylomicrons |
| Nongenetic (secondary) (12, 37, 40) |
| Hypothyroidism |
| Pregnancy (especially in the third trimester) |
| Poorly controlled diabetes |
| Obesity |
| Alcohol intake |
| Metabolic syndrome |
| Renal disease (nephrotic syndrome, glomerulonephritis) |
| Acute hepatitis |
| Diet (high saturated fat or high glycemic index) |
| Systemic lupus erythematosus |
| HIV |
| Cushing syndrome |
| Lipodystrophy |
| Glycogen storage disease |
| Drugs (12, 37, 40) |
| Nonselective β blockers |
| Corticosteroids |
| Oral estrogens |
| Diuretics (thiazides) |
| Tamoxifen, raloxifene |
| Androgens |
| Bile acid sequestrants |
| Cyclosporine |
| Atypical antipsychotics |
| Sirolimus, tacrolimus |
| l-asparaginase retinoic acid drugs (isotretinoin) |
| Cyclophosphamide |
| Protease inhibitors |
| Interferon |
Abbreviation: TC, total cholesterol.